Skip to main content Deutsch

Researcher of the Month - October 2022

Reduce the risk of cancer on screening day

MedUni Vienna and University Hospital Vienna invite you to Cancer Screening Day on February 15, 2025, 9 am to 1 pm

Skin cancer: New treatment option successfully tested

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumours in…

New combination immunotherapy for melanoma and breast cancer

Immunotherapy consisting of systemic interferon treatment and topical application of an active substance already used against basal cell carcinoma…

New therapeutic approach for aggressive type of brain tumor

(Vienna, 17 December 2024) Diffuse hemispheric glioma (DHG) is a brain tumor in children, adolescents and young adults with an average survival…

Cancer therapy: New option for the treatment of permanent hair loss

(Vienna, 10-12-2024) As much as targeted therapy using so-called EGFR inhibitors has proven its worth for various types of tumours, possible side…

Novel Model Enables Research of Individual Immune Responses for Colorectal Cancer

(Vienna, 15 November 2024) Predicting the optimal therapy for individual cancer patients is one of the most important goals of modern medicine. A…

Common Food Supplement could unlock cancer secret - Study shows selenium limitation could provide clue to new treatment

(Glasgow/Vienna, 22-October 2024) A study on an essential mineral abundant in brazil nuts could unlock the key to preventing the spread of triple…

Symposium: Leopold Freund - Pioneer of radiotherapy

As a pioneer of radiotherapy, Leopold Freund helped found and shape the "Vienna School of Radiotherapy". He was one of the first three physicians to…

CD-Labor für patient:innenzentrierte Brustbildgebung eröffnet - Forschung soll Brustkrebsdiagnostik sanfter, sicherer und smarter machen

Breast cancer, by far the most common cancer in women, is all the more treatable the earlier it is detected. At MedUni Vienna's newly opened Christian…

"Infinity enzyme" telomerase as a possible starting point for colon cancer therapies

A recent study led by Klaus Holzmann, Medical University of Vienna, Comprehensive Cancer Center Vienna, Center for Cancer Research, has shown that the…